Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1

View source ↗

Summary

Clinical trial update reporting results from a real-world data study evaluating the antiretroviral efficacy of the Dolutegravir/Rilpivirine combination in peopl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir/Rilpivirine (dolutegravir and rilpivirine)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Status: COMPLETED | Results posted: 2024-10-16